Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4226
Direxion Daily S&P Biotech Bear 3X ETF
LABD
$39.8M
| $3.78M | ﹤0.01% |
9,710
+673
| +7% | +$337K |
|
4227
Goldman Sachs ActiveBeta International Equity ETF
GSIE
$6.16B
| $3.78M | ﹤0.01% |
136,109
-151,528
| -53% | -$4.59M |
|
4228
Global X Silver Miners ETF NEW
SIL
$4.79B
| $3.77M | ﹤0.01% |
145,748
+62,784
| +76% | +$2.01M |
|
4229
CALL
Ashland
ASH
$3.38B
| $3.77M | ﹤0.01% |
36,600
+2,100
| +6% | +$215K |
|
4230
PUT
Northern Trust
NTRS
$35B
| $3.77M | ﹤0.01% |
39,100
-4,700
| -11% | -$497K |
|
4231
PUT
Levi Strauss
LEVI
$8.68B
| $3.77M | ﹤0.01% |
231,000
-93,300
| -29% | -$1.68M |
|
4232
Invesco BulletShares 2029 High Yield Corporate Bond ETF
BSJT
$578M
| $3.77M | ﹤0.01% |
189,150
-148
| -0.1% | -$3.14K |
|
4233
Magna International
MGA
$18.8B
| $3.77M | ﹤0.01% |
68,637
+33,376
| +95% | +$2.03M |
|
|
PVLA
4234
Palvella Therapeutics
PVLA
$2.25B
| $3.77M | ﹤0.01% |
25,176
-849
| -3% | -$155K |
|
4235
Madrigal Pharmaceuticals
MDGL
$11.7B
| $3.77M | ﹤0.01% |
52,587
-6,865
| -12% | -$505K |
|
4236
PUT
Beam Therapeutics
BEAM
$2.76B
| $3.76M | ﹤0.01% |
97,200
+22,800
| +31% | +$906K |
|
4237
Gran Tierra Energy
GTE
$325M
| $3.76M | ﹤0.01% |
327,256
+182,491
| +126% | +$2.91M |
|
4238
First American
FAF
$7.54B
| $3.76M | ﹤0.01% |
71,082
+40,556
| +133% | +$2.36M |
|
4239
PUT
iQIYI
IQ
$1.3B
| $3.76M | ﹤0.01% |
895,800
-231,000
| -21% | -$930K |
|
|
ACII
4240
DELISTED
Atlas Crest Investment Corp. II
ACII
| $3.76M | ﹤0.01% |
383,487
-495,723
| -56% | -$4.86M |
|
4241
PUT
Genco Shipping & Trading
GNK
$1.15B
| $3.76M | ﹤0.01% |
194,500
-54,000
| -22% | -$1.22M |
|
4242
Barings BDC
BBDC
$975M
| $3.75M | ﹤0.01% |
403,139
+64,721
| +19% | +$657K |
|
4243
PUT
Zions Bancorporation
ZION
$10.5B
| $3.75M | ﹤0.01% |
73,700
+12,500
| +20% | +$710K |
|
4244
CALL
West Pharmaceutical
WST
$24.6B
| $3.75M | ﹤0.01% |
12,400
-11,200
| -47% | -$3.64M |
|
4245
CALL
JPMorgan BetaBuilders Europe ETF
BBEU
$9.52B
| $3.75M | ﹤0.01% |
+81,300
| New | +$4.14M |
|
4246
CALL
Itaú Unibanco
ITUB
$81.6B
| $3.75M | ﹤0.01% |
991,715
-164,738
| -14% | -$732K |
|
4247
PUT
FTI Consulting
FCN
$4.19B
| $3.74M | ﹤0.01% |
20,700
+19,100
| +1,194% | +$3.15M |
|
4248
Tradr 2X Long Innovation ETFShort Innovation Daily ETF
SARK
$39.1M
| $3.74M | ﹤0.01% |
19,377
-53,149
| -73% | -$9.66M |
|
4249
PUT
dLocal
DLO
$4.17B
| $3.74M | ﹤0.01% |
+142,400
| New | +$3.65M |
|
4250
PUT
Global X Uranium ETF
URA
$6.27B
| $3.73M | ﹤0.01% |
201,200
-154,900
| -43% | -$3.49M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.